Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NeuroVasx has completed a private placement of common stock in the amount of $8.5 million with MJSK of Minneapolis, Minnesota, and the Stephens Group of Little Rock, Arkansas. Terms of the financing were not disclosed.
Subscribe to our email newsletter
The company also reported completion of long-term follow-up on 20 patients treated with the cPAX Aneurysm treatment system in a clinical study which was completed in May.
Eric Timko, president and CEO of NeuroVasx, said: “We are very pleased with the results we achieved in our clinical study. The long term follow-up data further supports the clinical effectiveness of cPAX. The company is eager to share the results of our study with the physician community.”